NCT01094847View on ClinicalTrials.gov

Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

May 31, 2010

Conditions
Bioequivalence
Interventions
DRUG

DWJ1252

tablet(oral) administration following the schedule of each arm

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT01094847 - Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine | Biotech Hunter | Biotech Hunter